?p=1269

Except as required by law, Lilly undertakes no duty to update forward-looking statements ?p=1269 to reflect events after the date of this release. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. The dividend is payable on June 9, 2023 to shareholders of record at the close of business on May 15, 2023.

About LillyLilly unites caring with discovery to create ?p=1269 medicines that make life better for people around the world. The dividend is payable on June 9, 2023 to shareholders of record at the close of business on May 15, 2023. The dividend is payable on June 9, 2023 to shareholders of record at the close of business on May 15, 2023. To learn more, visit Lilly.

Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission ?p=1269. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this ?p=1269 release. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. The dividend is payable on June 9, 2023 to shareholders of record at the close of business on May 15, 2023. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. The dividend is payable on June 9, 2023 to shareholders of record at the close of business ?p=1269 on May 15, 2023. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. To learn ?p=1269 more, visit Lilly. To learn more, visit Lilly. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ?p=1269 ensure our medicines are accessible and affordable. Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. The dividend is payable on June 9, 2023 to shareholders of record at the close of business on May 15, 2023.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. Form 10-K and Form 10-Q ?p=1269 filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.